PSMA-SulfoCy-5

N/A

Report date: 2023/06/27 15:01:08
NME

Base Information

Drug NamePSMA-SulfoCy-5
Drug Alias NamePSMA-SulfoCy5PSMA-SulfoCy-5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIzvarino Pharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A